Ftse Mib
34.242,49
0,75%
DAX
18.430,05
1,42%
S&P 500
5.187,70
0,13%
NASDAQ
16.332,56
-0,10%
Bitcoin
62.908,59
0,92%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ARCA Biopharma Inc (ABIO) ARCA Biopharma Inc (ABIO) Notizie

ABIO

ARCA Biopharma (ABIO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABIO
DataOraFonteTitoloSimboloCompagnia
25/04/202422:15GlobeNewswire Inc.ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
05/04/202419:09PR Newswire (US)Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law FirmNASDAQ:ABIOARCA Biopharma Inc
03/04/202413:30GlobeNewswire Inc.ARCA biopharma and Oruka Therapeutics Announce Merger AgreementNASDAQ:ABIOARCA Biopharma Inc
07/02/202419:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ABIOARCA Biopharma Inc
06/02/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABIOARCA Biopharma Inc
01/02/202422:35GlobeNewswire Inc.ARCA biopharma Announces 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
01/02/202422:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ABIOARCA Biopharma Inc
01/02/202400:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABIOARCA Biopharma Inc
19/12/202322:25Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ABIOARCA Biopharma Inc
19/12/202322:20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ABIOARCA Biopharma Inc
19/12/202322:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ABIOARCA Biopharma Inc
18/10/202322:25GlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
18/10/202322:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABIOARCA Biopharma Inc
11/09/202322:01Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ABIOARCA Biopharma Inc
21/07/202322:25GlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
24/04/202322:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABIOARCA Biopharma Inc
24/04/202322:25GlobeNewswire Inc.ARCA biopharma Announces First Quarter 2023 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
24/04/202322:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABIOARCA Biopharma Inc
24/02/202322:22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ABIOARCA Biopharma Inc
24/02/202322:20GlobeNewswire Inc.ARCA biopharma Announces 2022 Financial Results and Provides Corporate UpdateNASDAQ:ABIOARCA Biopharma Inc
19/12/202222:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABIOARCA Biopharma Inc
19/12/202222:18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ABIOARCA Biopharma Inc
19/12/202222:05GlobeNewswire Inc.James Flynn Joins ARCA biopharma Board of DirectorsNASDAQ:ABIOARCA Biopharma Inc
03/11/202221:26Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ABIOARCA Biopharma Inc
03/11/202221:19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ABIOARCA Biopharma Inc
28/10/202222:15GlobeNewswire Inc.ARCA biopharma Announces Third Quarter 2022 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
02/08/202222:15GlobeNewswire Inc.ARCA biopharma Announces Second Quarter 2022 Financial ResultsNASDAQ:ABIOARCA Biopharma Inc
08/07/202222:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ABIOARCA Biopharma Inc
21/06/202222:05GlobeNewswire Inc.Jacob Ma-Weaver Joins ARCA biopharma Board of DirectorsNASDAQ:ABIOARCA Biopharma Inc
05/05/202222:15GlobeNewswire Inc.ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options ReviewNASDAQ:ABIOARCA Biopharma Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABIO

La tua Cronologia

BIT
RACE
Ferrari NV
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ISP
Intesa Sanpaolo
BIT
CPR
Davide Campari
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
LDO
Leonardo
BIT
FBK
Finecobank
BIT
ENI
Eni
BIT
IRE
Iren
BIT
G
Generali
BIT
SRG
Snam
BIT
BAMI
Banco BPM
BIT
BPE
Bper Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network